C.E.M. Voorter

1.1k total citations
35 papers, 533 citations indexed

About

C.E.M. Voorter is a scholar working on Immunology, Hematology and Physiology. According to data from OpenAlex, C.E.M. Voorter has authored 35 papers receiving a total of 533 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Immunology, 7 papers in Hematology and 4 papers in Physiology. Recurrent topics in C.E.M. Voorter's work include T-cell and B-cell Immunology (23 papers), Immune Cell Function and Interaction (20 papers) and Immunotherapy and Immune Responses (14 papers). C.E.M. Voorter is often cited by papers focused on T-cell and B-cell Immunology (23 papers), Immune Cell Function and Interaction (20 papers) and Immunotherapy and Immune Responses (14 papers). C.E.M. Voorter collaborates with scholars based in Netherlands, Italy and Belgium. C.E.M. Voorter's co-authors include E.M. Van Den Berg‐Loonen, Maarten H. L. Christiaans, Wendy Swelsen, Marcel G.J. Tilanus, Marjolein Drent, Ilias I.N. Doxiadis, Massimo Amicosante, Otto Bekers, Patricia J. Nelemans and Ella van den Berg‐Loonen and has published in prestigious journals such as Blood, Haematologica and Immunogenetics.

In The Last Decade

C.E.M. Voorter

34 papers receiving 513 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
C.E.M. Voorter Netherlands	12	341	91	84	70	69	35	533
Saoussen Krid France	7	232 0.7×	110 1.2×	53 0.6×	37 0.5×	26 0.4×	23	372
Lena Marinova Austria	8	155 0.5×	141 1.5×	31 0.4×	28 0.4×	12 0.2×	21	361
Oliver Amon Germany	8	264 0.8×	35 0.4×	121 1.4×	125 1.8×	229 3.3×	17	543
Nicolò Ghiringhelli Borsa United States	13	552 1.6×	68 0.7×	247 2.9×	122 1.7×	15 0.2×	23	757
L. A. van Es Netherlands	7	179 0.5×	25 0.3×	39 0.5×	26 0.4×	14 0.2×	8	369
Utako Kaneko Japan	11	149 0.4×	26 0.3×	98 1.2×	28 0.4×	13 0.2×	29	334
W. M. Baldwin United States	9	146 0.4×	117 1.3×	36 0.4×	14 0.2×	19 0.3×	29	388
Krzysztof Suchnicki Poland	9	138 0.4×	15 0.2×	128 1.5×	152 2.2×	173 2.5×	16	398
M. Gokel Germany	7	195 0.6×	283 3.1×	30 0.4×	37 0.5×	17 0.2×	25	499
Shizunori Ichida Japan	7	148 0.4×	24 0.3×	58 0.7×	24 0.3×	19 0.3×	7	248

Countries citing papers authored by C.E.M. Voorter

Since Specialization

Citations

This map shows the geographic impact of C.E.M. Voorter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C.E.M. Voorter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C.E.M. Voorter more than expected).

Fields of papers citing papers by C.E.M. Voorter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C.E.M. Voorter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C.E.M. Voorter. The network helps show where C.E.M. Voorter may publish in the future.

Co-authorship network of co-authors of C.E.M. Voorter

This figure shows the co-authorship network connecting the top 25 collaborators of C.E.M. Voorter. A scholar is included among the top collaborators of C.E.M. Voorter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C.E.M. Voorter. C.E.M. Voorter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Voorter, C.E.M., et al.. (2024). HLA class I NK-epitopes and KIR diversities in patients with multiple myeloma. Immunogenetics. 76(3). 155–164. 2 indexed citations

Voorter, C.E.M., et al.. (2018). A new HLA‐C*05 allele, HLA‐C*05:156, characterized by full‐length hemizygous sequencing. HLA. 91(3). 212–213. 3 indexed citations

Walraven, Suzanna M. van, Anneke Brand, Martin B.A. Heemskerk, et al.. (2016). The increase of the global donor inventory is of limited benefit to patients of non-Northwestern European descent. Haematologica. 102(1). 176–183. 18 indexed citations

Voorter, C.E.M., et al.. (2015). RNA and protein expression of HLA-A∗23:19Q. Human Immunology. 76(4). 286–291. 6 indexed citations

Mascaretti, L, Carlo Carcassi, Thomas Eiermann, et al.. (2013). ACTIVITY OF EFI ACCREDITED LABORATORIES IN 2011: A PRELIMINARY ANALYSIS. Tissue Antigens. 81(5). 388–388. 1 indexed citations

Wijnen, Petal A., Patricia J. Nelemans, Johny Verschakelen, et al.. (2010). The role of tumor necrosis factor alpha G-308A polymorphisms in the course of pulmonary sarcoidosis. Tissue Antigens. 75(3). 262–268. 29 indexed citations

Voorter, C.E.M., et al.. (2008). Luminex donor‐specific crossmatches. Tissue Antigens. 71(6). 507–513. 45 indexed citations

Voorter, C.E.M., Kee‐Won Lee, David Smillie, Marcel G.J. Tilanus, & E.M. Van Den Berg‐Loonen. (2007). Sequence‐based typing of HLA‐DQA1: comprehensive approach showed molecular heterogeneity. Tissue Antigens. 69(s1). 76–81. 7 indexed citations

Voorter, C.E.M., et al.. (2007). HLA class II amino acid epitopes as susceptibility markers of sarcoidosis. Tissue Antigens. 70(1). 18–27. 33 indexed citations

10.

Voorter, C.E.M., et al.. (2005). Allelic polymorphism in introns 1 and 2 of the HLA‐DQA1 gene. Tissue Antigens. 65(1). 56–66. 6 indexed citations

11.

Faé, Ingrid, M. Lau, C.E.M. Voorter, Wolfgang R. Mayr, & Gottfried Fischer. (2004). HLA‐B*8102*, a new allele found in an external proficiency testing scheme. Tissue Antigens. 64(5). 608–610. 5 indexed citations

12.

Swelsen, Wendy, C.E.M. Voorter, & E.M. Van Den Berg‐Loonen. (2003). Polymorphism of intron 4 in HLA‐A, ‐B and ‐C genes. Tissue Antigens. 61(6). 475–483. 10 indexed citations

13.

Voorter, C.E.M. & E.M. Van Den Berg‐Loonen. (2002). Identification of two new HLA‐A alleles, A*2419 and A*3011, by sequence‐based typing. Tissue Antigens. 59(2). 136–138. 6 indexed citations

14.

Voorter, C.E.M., et al.. (2002). Identification of HLA‐A*0249 and confirmation of A*2615. Tissue Antigens. 60(6). 529–533. 5 indexed citations

15.

Voorter, C.E.M., Neubury M. Lardy, & E.M. Van Den Berg‐Loonen. (2000). Presence of the DRB4*0103102N null allele in different DRB1*04‐positive individuals. Tissue Antigens. 55(1). 37–43. 9 indexed citations

16.

Rozemuller, Erik H., et al.. (2000). DPB1*8501, a novel DPB1 variant in the US Black population. Tissue Antigens. 56(3). 282–284. 6 indexed citations

17.

Voorter, C.E.M., Marcel G.J. Tilanus, & E.M. Van Den Berg‐Loonen. (2000). Two new HLA DPB1 alleles identified by sequence‐based typing: DPB1*8201 and DPB1*8301. Tissue Antigens. 56(6). 560–562. 10 indexed citations

18.

Voorter, C.E.M., et al.. (2000). Sequence‐based typing of HLA‐B: the B7 cross‐reacting group. Tissue Antigens. 56(4). 356–362. 33 indexed citations

19.

Voorter, C.E.M., et al.. (1998). High‐resolution HLA typing for the DQB1 gene by sequence‐based typing. Tissue Antigens. 51(1). 80–87. 49 indexed citations

20.

Voorter, C.E.M., Marie‐Paule Emonds, & E.M. Van Den Berg‐Loonen. (1997). Identification of a new DRB4 allele (DRB4*0105) by sequence‐based typing. Tissue Antigens. 49(6). 662–664. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact